EARLY DIAGNOSIS, TREATMENT, AND PREVENTIVE STRATEGIES IN GYNECOLOGIC ONCOLOGY: AN ANALYTICAL REVIEW

Authors

  • GAVKHAR VOITOVA Tashkent State Medical University Author

Keywords:

Gynecologic oncology, early diagnosis, cervical cancer, ovarian cancer, HPV vaccination, prevention, treatment.

Abstract

Gynecologic cancers, including cervical, ovarian, endometrial, vulvar, and vaginal malignancies, represent a major global health burden among women. Early detection and timely intervention are critical to improving survival rates and quality of life. This paper analyzes current approaches to early diagnosis, treatment modalities, and preventive strategies in gynecologic oncology. Screening programs such as Pap smear and HPV testing remain the gold standard for cervical cancer detection, while imaging techniques and biomarker research are expanding opportunities for early ovarian and endometrial cancer identification. Treatment strategies range from surgery and radiotherapy to targeted therapy and immunotherapy, with personalized medicine gaining increasing relevance. Preventive measures, including HPV vaccination, genetic counseling, and lifestyle modifications, are crucial in reducing the incidence of these malignancies. The analysis underscores the need for multidisciplinary management, patient education, and health policy interventions to enhance outcomes

References

Bizzarri, N., & others. (2024). Prophylactic HPV vaccination in HPV-related gynecologic cancers: current evidence and gaps. International Journal of Gynecology & Obstetrics. Advance online publication. PubMed

Cho, H. W., et al. (2021). Updated clinical guideline for human papillomavirus vaccine. European Journal of Gynaecological Oncology. JGO Journal of Gynecologic Oncology

González-Rodríguez, J. C., et al. (2024). Cervical cancer prevention by vaccination: review. Frontiers in Oncology. Frontiers

Massad, L. S. (2009). The impact of human papillomavirus vaccination on gynecologic oncology. Gynecologic Oncology. Society of Gynecologic Oncology

Venturelli, F., & Multisociety Italian Guidelines Working Group. (2021). HPV vaccination in women treated for Cervical Intraepithelial Neoplasia grade 2 or 3: evidence-based recommendation. European Journal of Gynaecological Oncology, 42(5), 1039-1047. Ejgo

Schneiter, M. K., et al. (2022). Gynecologic oncology HPV vaccination practice patterns: survey among gynecologic oncologists. PMC (open access). PMC

Human Papillomavirus Vaccination Committee Opinion. (2020). Human papillomavirus vaccines: recommendations and efficacy. ACOG. Acog

Okhuhara, T., Okada, H., Goto, E., & Kiuchi, T. (2021). Readability assessment of HPV vaccination and cervical cancer information: a systematic scoping review. Healthcare, 9(10), 1246. https://doi.org/10.3390/healthcare9101246 MDPI

Updated clinical guideline for human papillomavirus vaccine. (2021). European Journal of Gynaecological Oncology. JGO Journal of Gynecologic Oncology

Adjuvant human papillomavirus vaccination for patients undergoing treatment for cervical intraepithelial neoplasia. (2023). ACOG Practice Advisory. Acog

Published

2025-10-08

How to Cite

EARLY DIAGNOSIS, TREATMENT, AND PREVENTIVE STRATEGIES IN GYNECOLOGIC ONCOLOGY: AN ANALYTICAL REVIEW . (2025). Eurasian Journal of Medical and Natural Sciences, 5(10), 52-58. https://in-academy.uz/index.php/EJMNS/article/view/10776